Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04666025 · ClinicalTrials.gov registry record
SARS-CoV-2 Donor-Recipient Immunity Transfer
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 26
- Enrollment target
NCT04666025 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT04666025 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This study investigates whether donors with previous exposure to COVID-19 can pass their immunity by hematopoietic (blood) stem cell transplant (HCT) donation to patients that have not been exposed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the COVID19 infection. This study may provide critical information for medical decision-making and possible immunotherapy interventions in immunocompromised transplant recipients, who are at high risk for COVID19 severe illness.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- OTHER Electronic Health Record Review
- OTHER Diagnostic Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2023-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04666025
The ClinicalTrials.gov registry entry for NCT04666025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT04666025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04666025 about?
NCT04666025 is a clinical study titled "SARS-CoV-2 Donor-Recipient Immunity Transfer". This study investigates whether donors with previous exposure to COVID-19 can pass their immunity by hematopoietic (blood) stem cell transplant (HCT) donation to patients that have not been exposed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the COVID19 inf...
What is the current status of trial NCT04666025?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2020-09-23. Estimated completion is 2023-05-05.
What interventions are being tested in trial NCT04666025?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Electronic Health Record Review (OTHER), Diagnostic Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT04666025?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.